The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 23, 2016
Filed:
Jun. 26, 2013
Applicant:
Takara Bio Inc., Shiga, JP;
Inventors:
Toshikazu Nishie, Shiga, JP;
Fuyuko Takashima, Shiga, JP;
Tatsuji Enoki, Shiga, JP;
Junichi Mineno, Shiga, JP;
Assignee:
TAKARA BIO INC., Shiga, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/10 (2006.01); C12N 15/86 (2006.01); C12N 15/09 (2006.01); C12N 15/11 (2006.01); C12N 7/00 (2006.01); C12N 15/64 (2006.01); C12P 19/34 (2006.01);
U.S. Cl.
CPC ...
C12N 15/86 (2013.01); C12N 5/10 (2013.01); C12N 7/00 (2013.01); C12N 15/09 (2013.01); C12N 15/111 (2013.01); C12N 15/64 (2013.01); C12P 19/34 (2013.01); C12N 2310/141 (2013.01); C12N 2330/51 (2013.01); C12N 2750/14143 (2013.01); C12N 2750/14151 (2013.01);
Abstract
According to the present invention, an AAV vector having a higher titer compared with those of conventional ones can be produced using a cell into which a nucleic acid capable of expressing miRNA is introduced artificially. An AAV vector produced using the cell and a composition containing the viral vector as an active ingredient are very useful as gene transfer means in the studies or clinical practice of gene therapies.